Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6415289rdf:typepubmed:Citationlld:pubmed
pubmed-article:6415289lifeskim:mentionsumls-concept:C0001465lld:lifeskim
pubmed-article:6415289lifeskim:mentionsumls-concept:C0031711lld:lifeskim
pubmed-article:6415289lifeskim:mentionsumls-concept:C0917785lld:lifeskim
pubmed-article:6415289lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:6415289lifeskim:mentionsumls-concept:C2611155lld:lifeskim
pubmed-article:6415289lifeskim:mentionsumls-concept:C1706498lld:lifeskim
pubmed-article:6415289pubmed:issue2lld:pubmed
pubmed-article:6415289pubmed:dateCreated1983-12-17lld:pubmed
pubmed-article:6415289pubmed:abstractTextThe binding sites for the allosteric activator, AMP, to glycogen phosphorylase b are described in detail utilizing the more precise knowledge of the native structure obtained from crystallographic restrained least-squares refinement than has hitherto been available. Localized conformational changes are seen at the allosteric effector site that include shifts of between 1 and 2 A for residues Tyr75 and Arg309 and very small shifts for the region of residues 42 to 44 from the symmetry-related subunit. Kinetic studies demonstrate that NADH inhibits the AMP activation of glycogen phosphorylase b. Crystallographic binding studies at 3.5 A resolution show that NADH binds to the same sites on the enzyme as AMP, i.e. the allosteric effector site N, which is close to the subunit-subunit interface, and the nucleoside inhibitor site I, which is some 12 A from the catalytic site. The conformations of NADH at the two sites are different but both conformations are "folded" so that the nicotinamide ring is close (approx. 6 A) to the adenine ring. These conformations are compared with those suggested from solution studies and with the extended conformations observed in the single crystal structure of NAD+ and for NAD bound to dehydrogenases. Possible mechanisms for NADH inhibition of phosphorylase activation are discussed.lld:pubmed
pubmed-article:6415289pubmed:languageenglld:pubmed
pubmed-article:6415289pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6415289pubmed:citationSubsetIMlld:pubmed
pubmed-article:6415289pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6415289pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6415289pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6415289pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6415289pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6415289pubmed:statusMEDLINElld:pubmed
pubmed-article:6415289pubmed:monthOctlld:pubmed
pubmed-article:6415289pubmed:issn0022-2836lld:pubmed
pubmed-article:6415289pubmed:authorpubmed-author:WilsonK SKSlld:pubmed
pubmed-article:6415289pubmed:authorpubmed-author:JohnsonL NLNlld:pubmed
pubmed-article:6415289pubmed:authorpubmed-author:SturaE AEAlld:pubmed
pubmed-article:6415289pubmed:authorpubmed-author:SansomM SMSlld:pubmed
pubmed-article:6415289pubmed:authorpubmed-author:ZanottoAAlld:pubmed
pubmed-article:6415289pubmed:authorpubmed-author:Van de...lld:pubmed
pubmed-article:6415289pubmed:authorpubmed-author:StuartD IDIlld:pubmed
pubmed-article:6415289pubmed:authorpubmed-author:BabuY SYSlld:pubmed
pubmed-article:6415289pubmed:issnTypePrintlld:pubmed
pubmed-article:6415289pubmed:day25lld:pubmed
pubmed-article:6415289pubmed:volume170lld:pubmed
pubmed-article:6415289pubmed:ownerNLMlld:pubmed
pubmed-article:6415289pubmed:authorsCompleteYlld:pubmed
pubmed-article:6415289pubmed:pagination529-65lld:pubmed
pubmed-article:6415289pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6415289pubmed:meshHeadingpubmed-meshheading:6415289-...lld:pubmed
pubmed-article:6415289pubmed:meshHeadingpubmed-meshheading:6415289-...lld:pubmed
pubmed-article:6415289pubmed:meshHeadingpubmed-meshheading:6415289-...lld:pubmed
pubmed-article:6415289pubmed:meshHeadingpubmed-meshheading:6415289-...lld:pubmed
pubmed-article:6415289pubmed:meshHeadingpubmed-meshheading:6415289-...lld:pubmed
pubmed-article:6415289pubmed:meshHeadingpubmed-meshheading:6415289-...lld:pubmed
pubmed-article:6415289pubmed:meshHeadingpubmed-meshheading:6415289-...lld:pubmed
pubmed-article:6415289pubmed:meshHeadingpubmed-meshheading:6415289-...lld:pubmed
pubmed-article:6415289pubmed:meshHeadingpubmed-meshheading:6415289-...lld:pubmed
pubmed-article:6415289pubmed:meshHeadingpubmed-meshheading:6415289-...lld:pubmed
pubmed-article:6415289pubmed:meshHeadingpubmed-meshheading:6415289-...lld:pubmed
pubmed-article:6415289pubmed:meshHeadingpubmed-meshheading:6415289-...lld:pubmed
pubmed-article:6415289pubmed:meshHeadingpubmed-meshheading:6415289-...lld:pubmed
pubmed-article:6415289pubmed:meshHeadingpubmed-meshheading:6415289-...lld:pubmed
pubmed-article:6415289pubmed:year1983lld:pubmed
pubmed-article:6415289pubmed:articleTitleComparison of AMP and NADH binding to glycogen phosphorylase b.lld:pubmed
pubmed-article:6415289pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6415289pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:6415289pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6415289lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6415289lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6415289lld:pubmed